52:08

Team Science Across the NJ ACTS Consortium - April 2024

01:01:52

NJ ACTS Pilot Program 2024 Webinar

55:58

NJ ACTS Special Populations Seminar - 4/30/24

59:48

NJ ACTS Special Populations Seminar - 3/27/24

56:43

Team Science Across the NJ ACTS Consortium - March 2024

55:06

NJ ACTS Special Populations Seminar Series - 2/27/2024

58:14

Team Science Across the NJ ACTS Consortium Virtual Workshop Series - 12/2023

01:00:02

NJ ACTS Special Populations Seminar - 11/28/23

01:00:52

NJ ACTS Special Populations Seminar - 10/31/23

46:19

NJ ACTS Special Populations Seminar -12/5/23

52:26

Team Science Across the NJ ACTS Consortium Virtual Workshop Series - 10/19/23

55:51

NJ ACTS Special Populations Seminar Series - 9/23/-23

58:51

NJ ACTS Special Populations Seminar Series - 1/31/23

01:00:21

NJ ACTS Special Populations Seminar Series - June 13, 2023

58:08

NJ ACTS Special Populations Core Seminar Series - 5/24/23

58:46

Team Science Across the NJ ACTS Consortium Virtual Workshop Series - April 20, 2023

58:24

NJ ACTS Special Populations Core Seminar Series, 4-25-23

58:44

NJ ACTS Special Populations Core Seminar Series - 3/21/23

57:39

NJ ACTS Special Populations Core Seminar Series - 2/28/2023

54:07

Team Science Across the NJ ACTS Consortium Workshop Series - The Corona Cohort Study

59:59

Team Science Across the NJ ACTS Consortium - Fragile Families Third Generation (FFG3)

01:00:15

Team Science Across the NJ ACTS Consortium - MINT (Myocardial Ischemia and Transfusion) Trial

56:17

NJ ACTS Special Populations Core 2022 Seminar Series - 12/6/22

01:00:13

NJ ACTS Special Populations Core 2022 Seminar Series

01:00:48

NJ ACTS Special Populations Core 2022 Seminar Series - 10/25/22

53:10

NJ ACTS Special Population Core 2022 Seminar Series - 6/14/22

58:55

NJ ACTS Special Populations Core 2022 Seminar Series - 9/13/22

09:30

Informed Consent

09:29

Phase III and IV Clinical Trials

09:24

Phase I and II Clinical Trials

07:43

Types of IRB Reviews

05:27

Special Populations

06:15

What is an IRB?

07:51

Preclinical Development

59:12

Team Science Team Building Seminar Series - 11/15/21

55:28

Team Science Team Building Seminar Series - 3/30/22

55:06

NJ ACTS Special Populations Seminar - April 12, 2022

02:12

NJ ACTS- A TL1 Fellow Perspective

53:03

Special Populations Core Seminar Series

01:02:15

Team Science Team Building Seminar Series - 1/24/22

58:21

Special Populations Core Seminar Series, 2/8/22

01:04:24

Team Science Core Seminar - 1/31/22

59:20

NJ ACTS Special Populations Seminar Series

01:00:44

Large Scale Population Studies Focused on Serious Mental Illness and Disparities

03:26

Medical Supplies Needed by Underserved Countries

04:41

Randomized Controlled Trial of Tailored Music Listening Intervention for Sleep in Dementia

05:33

Higher Concentration of Bacterial Enveloped Virus Phi6 Can Protect Virus from Environmental Decay

03:10

The Feasibility, Acceptability and Preliminary Efficacy of an mHeatlh Mindfulness Therapy

05:01

Remote Evaluation of Upper Extremity Motor Function in Persons with Stroke

03:27

A FRET-based HTS to Identify Antibacterial Drug Leads Targeting Ternary Complex Formation

43:53

AI for Healthcare Disparities: A Double-Edged Sword

32:37

Host Microbiome Interactions in Health and Disease

16:07

Detecting, Reporting and Alleviating Racial Biases in Standardized Medical Terminologies/Ontologies

15:02

Leveraging Massively Parallel Reporter Assays

37:43

Impact of COVID-19 Pandemic on Clinical Trials: Lessons Learned and Opportunities to be Gained

34:42

Racism and Social Determinants of Health

15:23

Characteristics of Patients Who Received a COVID-19 Vaccine in the Emergency Department

21:34

Innovative Transformation of the RWJMS Clinical Research Center

07:46

Preclinical Drug Development

09:14

Defining and Reporting Adverse Drug Events